Clinical Trial Update: Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating transdermal rotigotine as an adjunct to behavioral therapy for cocaine use disorder and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Use Disorder

Drugs mentioned

• Rotigotine (Neupro) (rotigotine)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Substance-Related Disorders | Phase 2 | Status: RECRUITING